MedTrace Logo

Diagnostic Accuracy and Safety of the Attention-Deficit/Hyperactivity Disorder Auxiliary Evaluation System (AHEF) in Chinese Children Aged 6 to 12

NCT07683156 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 570

Last updated 2026-07-29

No results posted yet for this study

Summary

This clinical trial aims to evaluate the diagnostic efficacy and safety of the Attention Deficit Hyperactivity Disorder Assessment System (AHEF) in children aged 6 to 12 in China, while ensuring the safety of the subjects and maintaining the scientific integrity of the clinical trial.

Conditions

  • Attention-Deficit
  • Hyperactivity Disorder

Interventions

DIAGNOSTIC_TEST

AHEF

Assisted assessment system for attention deficit hyperactivity disorder: All participants who pass the screening must undergo the assessment using this assisted system.

Sponsors & Collaborators

  • Chongqing Jinsaixing Medical Technology Co., Ltd

    lead INDUSTRY

Eligibility

Min Age
6 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-07-31
Primary Completion
2027-01-30
Completion
2027-04-04

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07683156 on ClinicalTrials.gov